Clinical trial
Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms
NCT00408954 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00408954 |
|---|---|
| Title | Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms |
| Official title | A Multi Center Randomized Cross Over Double Blind Third Party Open Placebo Controlled Pilot Study to Assess the Urodynamic Effects of Modified Release UK-369,003 in Men With Lower Urinary Tract Symptoms. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | UK-369, 003 |
| Enrollment | 27 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Dec 8, 2006 |
| Last update posted | Nov 23, 2010 |
| Countries | Czechia, Netherlands, Slovakia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: